Synchronoss Technologies (SNCR) Prices 38.4M Offering at $2.6/sh

Go back to Synchronoss Technologies (SNCR) Prices 38.4M Offering at $2.6/sh

After-Hours Stock Movers 06/24: (TNXP) (NKE) (SNX) Higher; (TBPH) (SNCR) (FDX) Lower (more...)

June 24, 2021 5:49 PM EDT

After-Hours Stock Movers

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.6% HIGHER; Dr. Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, said today that plans are advancing to construct a commercial-scale manufacturing facility to develop and manufacture vaccines in the Bitterroot Valley.

Theravance Biopharma, Inc. (NASDAQ: TBPH) 9.2% LOWER; announced today that it intends to offer its ordinary shares in an underwritten public offering. Theravance Biopharma also intends to... More

Synchronoss Technologies (SNCR) to Offer $100M in Common Stock

June 24, 2021 5:32 PM EDT

Synchronoss Technologies, Inc. (NASDAQ: SNCR) today announced that the Company intends to offer and sell, subject to market and other conditions, $100 million of shares of its common stock in an underwritten public offering. Synchronoss also expects to grant the underwriters a 30-day option to... More